Trial Information
Inclusion Criteria:
- The participants should be healthy,
- non-pregnant adults who weigh at least 50kgs
Exclusion Criteria:
- Age of < 22 and > 80 years old.
- Pregnancy (women of childbearing potential: Refusal or inability to use effective
means of contraception)
- Decision of unsuitableness by Principal Investigator or physician-in-charge.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
To identify HLA-A1101-restricted peptide epitopes derived from novel Oncoantigens (URLC10, KIF20A, and CDCA1) applicable for Cancer Vaccine in Singapore.
Authority:
Singapore : Domain Specific Review Boards (DSRB)
Study ID:
KK001
NCT ID:
NCT01570439
Start Date:
January 2012
Completion Date:
Related Keywords:
- Anonymous Donors at Blood Donation Center (NUH)